Ci sono aggiornamenti al trapianto di cellule staminali per la terapia con cellule staminali?
Trapianto di cellule staminali emopoietiche (HSCT) è un trattamento chemioterapico intenso per la SM. Ha lo scopo di fermare i danni causati dalla SM annientando e poi rigenerando il sistema immunitario, using your stem cells.
HSCT (Trapianto di cellule staminali emopoietiche) attempts to “reboot” the immune system, which is responsible for damaging the brain and spinal cord in MS. In HSCT for MS, emopoietico (blood cell-producing) cellule staminali, which are derived from a person’s own (scientifically referred to as “autologous”) bone marrow or blood, are collected and stored, prior to depleting much of the immune system using chemotherapy drugs. Then the stored hematopoietic stem cells are reintroduced to the body. The new stem cells migrate to the bone marrow and over time reconstitute the immune system.
